Dynamics of Choline-Containing Phospholipids in Traumatic Brain Injury and Associated Comorbidities

Abstract

The incidences of traumatic brain injuries (TBIs) are increasing globally because of expanding population and increased dependencies on motorized vehicles and machines. This has resulted in increased socio-economic burden on the healthcare system, as TBIs are often associated with mental and physical morbidities with lifelong dependencies, and have severely limited therapeutic options. There is an emerging need to identify the molecular mechanisms orchestrating these injuries to life-long neurodegenerative disease and a therapeutic strategy to counter them. This review highlights the dynamics and role of choline-containing phospholipids during TBIs and how they can be used to evaluate the severity of injuries and later targeted to mitigate neuro-degradation, based on clinical and preclinical studies. Choline-based phospholipids are involved in maintaining the structural integrity of the neuronal/glial cell membranes and are simultaneously the essential component of various biochemical pathways, such as cholinergic neuronal transmission in the brain. Choline or its metabolite levels increase during acute and chronic phases of TBI because of excitotoxicity, ischemia and oxidative stress; this can serve as useful biomarker to predict the severity and prognosis of TBIs. Moreover, the effect of choline-replenishing agents as a post-TBI management strategy has been reviewed in clinical and preclinical studies. Overall, this review determines the theranostic potential of choline phospholipids and provides new insights in the management of TBI.

Combination of levetiracetam with sodium selenite prevents pentylenetetrazole-induced kindling and behavioral comorbidities in rats

“…The treatment of epilepsy has been a huge challenge for neurologists due to the high refractoriness of current therapy ( Javaid et al, 2021 , Javaid et al, 2021 ). The mainstay of therapy targets not only to protect the patient from seizure episodes but to improve the patient’s overall well-being by maintaining the psychosocial activities and evading the toxicities imposed by long-term drug use ( Goldenberg, 2010 ).…”

An Atlas of the Quantitative Protein Expression of Anti-Epileptic-Drug Transporters, Metabolizing Enzymes and Tight Junctions at the Blood–Brain Barrier in Epileptic Patients

“…Epilepsy is one of the most common central nervous system (CNS) disorders, with an incidence of approximately 1% of the population. Post-traumatic epilepsy as a comorbidity of traumatic brain injuries is also becoming a universal challenge for brain health due to the increasing incidence of brain trauma [1]. About one third of patients eventually develop drug resistance to some anti-epileptic drugs (AEDs) and fail to respond to treatment with medication [2], although a variety of combination pharmacotherapy of multiple drugs was investigated [3].…”

Effects of choline containing phospholipids on the neurovascular unit: A review

“…Choline plays a prominent role in the synthesis of different membrane phospholipids (Javaid et al, 2021). Moreover, choline is essential for cholinergic neurons to synthesize the neurotransmitter acetylcholine.…”

“…Phosphatidylcholine is the main form of phosphoglycerides that contains the choline molecule as the head group. It represents the main phospholipid of the outer layer of the cellular and intracellular membranes of mammalian cells, and it accounts for 32.8% of the total glycerophospholipid content of the human brain (Javaid et al, 2021). The synthesis could be mediated by the direct methylation of the ethanolamine residue of phosphatidylethanolamine or via the Kennedy pathway.…”

“…The synthesis could be mediated by the direct methylation of the ethanolamine residue of phosphatidylethanolamine or via the Kennedy pathway. Choline molecules are phosphorylated by choline kinases, which after processing by cytidylyltransferase, generated CDP-choline, which further couples with phosphatidic acid and gives phosphatidylcholine (Javaid et al, 2021). Other CCPLs such as sphingomyelin, are abundant in the myelin sheath and contribute to maintain the integrity of the axonal covering (Javaid et al, 2021).…”